Phase 4CompletedAge-related condition

This Study Uses Ultrasound to Determine Whether Atorvastatin or Pravastatin Effects the Progression of Coronary Plaque.

A Prospective, Randomized, Double-Blind, Multi-Center Study Comparing the Effects of Atorvastatin Versus Pravastatin on the Progression and Quantification of Coronary Atherosclerotic Lesions as Measured by Intravascular Ultrasound (REVERSAL)

Sponsor
Pfizer (Industry)
Enrollment
600 planned
Conditions
Coronary Arteriosclerosis
Interventions
Atorvastatin; Pravastatin
Ages
adults, older adults
Registry
NCT00380939

Full record on ClinicalTrials.gov

From the registry

This study was designed to assess the effects on coronary artery plaque using aggressive lipid-lowering therapy versus moderate lipid-lowering therapy. A substudy will examine the effect of these treatments on brachial artery vasoactivity.

Primary outcomes

  • The primary efficacy parameter is the percent change in total plaque volume for all slices of anatomically comparable segments of the target coronary artery from baseline to month 18.
  • The primary efficacy parameter for brachial artery vasoactivity is the nominal change (month 3 - baseline) in the percent arterial diameter change.

History

  1. Last registry update

  2. Registered

  3. Study completion

  4. Started